January 11, 2020 5:45pm

9 out of the 19 downside had higher than the 3 month average volume while 12 out of the 16 upside had higher than the 3 month average volume

Preopen indications: 3 HITs <AGTC -$1.43, GBT -$0.41 and SLDB -$0.19)> and 3 MISS < (SAGE -$1.42), MESO +$0.03) and RARE (+$10.23)>

Week in review - “numbers”

I make a commitment to provide need-to-know “facts in evidence” as equity’s volatility is one tactical signal for stocks.

 

The Dow closed DOWN -133.13 points (-0.46%), the S&P closed DOWN -9.35 points (-0.29%) and the NASDAQ closed DOWN -24.57points (-0.27%)

 

Henry’omics:

Indexes fell on Friday, reversing from all-time highs, as investors digested weaker-than-expected jobs data to end a volatile week full of geopolitical concerns.

The major averages still posted solid weekly gains despite Friday’s muted performance. The DOW was ++0.07%, the S&P 500 was up +0.09% and NASDAQ was up +1.8% for the week.

From my morning “Data Docket”, the U.S. economy added 145,000 jobs in December. Economists polled expected the U.S. economy to have added 160,000 jobs in December. Wages also disappointed, growing by just 2.9% on a year-over-year basis. Economists had forecast a gain of 3.1%. December was also the first month since July 2018 that wages grew by less than 3% from the year before <CNBC>.

The December jobs report was a little softer than expected!

 

JPMorgan will de-materialize many share pricings unless … there is NEWS of clinical results or an acquisition or two!

Key words .... perception and ... exposure!

 

The iShares NASDAQ Biotechnology (IBB) and the SPDR S&P ETF (XBI) indicators:

  • Friday the IBB closed down -0.59% while and XBI closed down -0.99%
  • Thursday the IBB closed up +0.82% while and XBI closed UP +0.21%
  • Wednesday the IBB closed up +1.07% while and XBI closed UP +1.29%
  • Tuesday the IBB closed up +0.03% while and XBI closed UP +0.15%
  • Monday the IBB closed up +0.76% while and XBI closed UP +0.81%

 

The advance/decline line scenario of 45 covered companies:

  • Friday the close was negative with an A/D line of 16/19 , 1 flat of 36 covered,
  • Thursday the close was positive with an A/D line of 22/13 , 1 flat of 36 covered,
  • Wednesday the close was positive with an A/D line of 23/11 , 2 flat of 36 covered,
  • Tuesday the close was positive with an A/D line of 22/14 , 0 flat of 36 covered,
  • Monday the close was positive with an A/D line of 22/14 , 0 flat of 36 covered,

 

Decliners:

  • CRISPR Therapeutics (CRSP -$2.00 after Thursday’s -$0.63 and Wednesday’s +$2.18);
  • Applied Genetic Technologies (AGTC -$1.43 after Thursday’s +$6.11);
  • uniQure NV (QURE -$0.08 after Thursday’s +$1.46 and Wednesday’s-$0.45);
  • BioLife Solutions (BLFS -$0.65);
  • Ionis Pharmaceuticals (IONS -$0.59);

Incliners:

  • Ultragenyx (RARE +$10.23 after Thursday’s -$1.40);
  • Regenxbio (RGNX +$1.88 after Thursday’s +$1.45);
  • Alnylam Pharmaceuticals (ALNY +$1.19 after Thursday’s +$2.59);
  • Sage Therapeutics (SAGE +$1.12);
  • Cellectis SA (CLLS +$0.98);

 

The percentage (%) indicators:

  • Friday’s range of the 16 upside was +0.10% (EDIT) to +10.23% (RARE) while the 19 downside ranged from -0.02% (BOLD) to -15.43% (AGTC); 
  • Thursday’s range of the 22 upside was +0.02% (BOLD) to +122.84% (AGTC) while the 13 downside ranged from -0.18% (FATE) to -14.45% (SLDB); 
  • Wednesday’s range of the 23 upside was +0.16% (ALNY) to +36.41% (VSTM) while the 11 downside ranged from -0.03% (BOLD) to -3.23% (ATHX); 
  • Tuesday’s range of the 22 upside was +0.28% (BLUE) to +23.79% (BSTG) while the 14 downside ranged from -0.02% (BOLD) to -3.82% (VSTM); 
  • Monday’s range of the 22 upside was +0.12% (IONS) to +9.92% (ADRO) while the 14 downside ranged from -0.15% (VYGR) to -8.57% (BLCM); 

 

Upside volume stats:  to compare

  • Friday: 12 out of the 16 upside had higher than the 3 month average volume;
  • Thursday: 9 out of the 22 upside had higher than the 3 month average volume;
  • Wednesday: 6 out of the 23 upside had higher than the 3 month average volume;
  • Tuesday: 7 out of the 22 upside had higher than the 3 month average volume;
  • Monday: 7 out of the 22 upside had higher than the 3 month average volume;

Downside volume stats:

  • Friday: 9 out of the 19 downside had higher than the 3 month average volume;
  • Thursday: 4 out of the 13 downside had higher than the 3 month average volume;
  • Wednesday: 4 out of the 11 downside had higher than the 3 month average volume;
  • Tuesday: 3 out of the 14 downside had higher than the 3 month average volume;
  • Monday: 6 out of the 14 downside had higher than the 3 month average volume;

1 flat – RENE.L

 

January’s sessions of 36 covered companies:

Friday closed NEGATIVE with 19 decliners, 16 advancers and 1 flat;

Thursday closed POSITIVE with 13 decliners, 22 advancers and 1 flat;

Wednesday closed POSITIVE with 11 decliners, 23 advancers and 2 flats;

Tuesday closed POSITIVE with 14 decliners, 22 advancers and 0 flat;

Monday closed POSITIVE with 14 decliners, 22 advancers and 0 flat;

Friday closed NEGATIVE with 20 decliners, 15 advancers and 1 flat;

Thursday closed NEGATIVE with 19 decliners, 15 advancers and 2 flats;

Wednesday markets were closed;

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.